OK - So yesterday NICE approved Harvoni, DAC and the AbbVie. For restricted use on NHS England.
However, Nothing will be implemented for 3 months, rumour has it Feb/March 2016.
The details for GT3 are very vague and they have not addressed this GT properly.
Many hospitals have been devolved from central Gvt and are hugely in debt and will not have the budget.
There will be waiting lists and post-code lottery.
For GT1 Tx naive only 8 weeks Harvoni.
and not all treatments the EASL recommended duration.s.
As a treatment 'guidance' (but I believe not legally in the small print) We should all have access to the approvals as listed by NICE and they have 3 months to implement this according to the HepC Trust
A pleasing step in the right direction, but maybe not all it's cracked up to be in the headlines.
We watch, and wait? The reality for many is one - two years away.
GT1a Dec14 F2/8.7 VL 900000-2.5M
Jan16 Hepcivir-L MonkMed/Redemption
Baseline: VL 913575 Alt 76 Platelets low
Wk2 VL1157 Alt 23
DET Wk 8 VL 32 Alt19 'In the slow lane'
June16 Fibro 5.7 F0/1 LIF 1.5
Wk 11 VL<12 Alt 13 Det/Unq
Extending tx 12 wks Mylan Sofo/Dac MonkMed
Wk 14 VL <12 Det/Unq
Wk 16 VL UNDETECTED
Wk 22 + 4 Wks Sunprevir FixHepC
Wk 24 UNDETECTED Alt 13
Wk 12 post tx SVR12 Wk 26 SVR24
Thank-you Tim, Dr Debasis @ MonkMed & Dr Freeman @ Fix HepC